23 May 2013
Keywords: trovax, yields, median, pfs, months, french, drug
Article | 16 June 2008
French drug major Sanofi-Aventis and UK-based Oxford BioMedica reported encouraging results from Phase II trials of TroVax in metastatic renal
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2008
22 May 2013
© 2013 thepharmaletter.com